Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TACR3 | P29371 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2843685 | 0.79 | PTGER4 (0.48) | PTGER4TP53MEN1KMT2AMAPT | |
| SCHEMBL2870198 | 0.79 | PTGER4 (0.48) | PTGER4TP53MEN1KMT2AMAPT | |
| SCHEMBL14003140 | 0.78 | ALDH1A1 (0.53) | CNR2PTGER4MAPK1MEN1KMT2A | |
| SCHEMBL13889613 | 0.78 | ALDH1A1 (0.53) | CNR2PTGER4MAPK1MEN1KMT2A | |
| SCHEMBL13011093 | 0.75 | CNR2 (0.81) | CNR2TAS1R3TAS1R1MAPK1CTSL | |
| SCHEMBL13011099 | 0.75 | CNR2 (0.81) | CNR2TAS1R3TAS1R1MAPK1CTSL | |
| SCHEMBL14258996 | 0.74 | CNR2 (0.82) | CNR2TAS1R3TAS1R1MAPK1CTSL | |
| SCHEMBL14258998 | 0.74 | CNR2 (0.82) | CNR2TAS1R3TAS1R1MAPK1CTSL | |
| SCHEMBL14258995 | 0.74 | CNR2 (0.82) | CNR2TAS1R3TAS1R1MAPK1CTSL | |
| SCHEMBL14089790 | 0.74 | CNR2 (0.82) | CNR2TAS1R3TAS1R1MAPK1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234347-A1 | METHOD FOR TREATING CB2 RECEPTOR MEDIATED PAIN | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-09-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234347-A1 | METHOD FOR TREATING CB2 RECEPTOR MEDIATED PAIN | CNR2, CNR1, NPY4R | CNR2 1/4885PTGER4 89/4885PPARG 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.